A practice guideline on Wilson disease

Hepatology

Volumn 37, Issue 6, 2003, Pages 1475-1492

  Roberts, Eve A ^a   Schilsky, Michael L ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; COPPER; DIMERCAPROL; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC;

APLASTIC ANEMIA; CHEMICAL ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MECHANISM; DRUG SCREENING; ELASTOSIS; FEVER; FOOD DRUG INTERACTION; GASTRITIS; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LEUKOPENIA; LIVER BIOPSY; LIVER TOXICITY; LIVER TRANSPLANTATION; LUPUS VULGARIS; NEPHROTIC SYNDROME; NEUTROPENIA; PANCREATITIS; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; RASH; RETINITIS; REVIEW; SIDE EFFECT; SIDEROBLASTIC ANEMIA; SKIN DISEASE; THROMBOCYTOPENIA; WILSON DISEASE; ZINC METABOLISM;

EID: 0037566015     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50252     Document Type: Review

References (208)

1. Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE, Jr., et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994;18:421.
2. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295-507.
3. Fleischer B. Ueber einer der "Pseudosclerose" nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische Stoerungen, braeunlicke Pigmentierung bestimmter Gewebe, insbesondere Such der Hornhauptperipherie, Lebercirrhose). Deutsch Z Nerven Heilk 1912;44:179-201.
4. Bearn AG. A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration). Ann Hum Genet 1960;24:33-43.
5. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-337.
6. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.
7. Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 1993;5:338-343.
8. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-277.
9. Holtzman NA, Gaumnitz BM. Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J Biol Chem 1970;245:2354-2358.
10. Frydman M. Genetic aspects of Wilson's disease. J Gastroenterol Hepatol 1990;5:483-490.
11. Cumings JN. The effect of BAL in hepatolenticular degeneration. Brain 1951;74:10-22.
12. Denny-Brown D, Porter H. The effect of BAL (2,3 dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med 1951;245:917-925.
13. Walshe JM. Wilson's disease. New oral therapy. Lancet 1956;i:25-26.
14. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952;116:484-485.
15. Sternlieb I. Perspectives on Wilson's disease. HEPATOLOGY 1990;12:1234-1239.
16. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-218.
17. Walshe JM. The liver in Wilson's disease. In: Schiff L, Schiff ER, editors. Diseases of the Liver. 6th ed. Philadelphia: Lippincott, 1987:1037-1050.
18. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987;146:261-265.
19. Scott J, Gollan JL, Samourian S, Sherlock S. Wilson's disease, presenting as chronic active hepatitis. Gastroenterology 1978;74:645-651.
20. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991;100:762-767.
21. Milkiewicz P, Saksena S, Hubscher SG, Elias E. Wilson's disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol 2000;15:570-574.
22. Azizi E, Eshel G, Aladjem M. Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr 1989;148:548-549.
23. Nakada SY, Brown MR, Rabinowitz R. Wilson's disease presenting as symptomatic urolithiasis: a case report and review of the literature. J Urol 1994;152:978-979.
24. Chu CC, Huang CC, Chu NS. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease. Nephron 1996;73:477-479.
25. Golding DN, Walshe JM. Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients. Ann Rheum Dis 1977;36:99-111.
26. Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases. Virchows Arch [Pathol Anat] 1982;397:301-311.
27. Kuan P. Cardiac Wilson's disease. Chest 1987;91:579-583.
28. Hlubocka Z, Maracek Z, Linhart A, Kejrova E, Pospisilova L, Martasek P, et al. Cardiac involvement in Wilson disease. J Inherit Metab Dis 2002;25:269-277.
29. Weizman Z, Picard E, Barki Y, Moses S. Wilson's disease associated with pancreatitis. J Pediatr Gastroenterol Nutr 1988;7:931-933.
30. Carpenter TO, Carnes DL, Jr., Anast CS. Hypoparathyroidism in Wilson's disease. N Engl J Med 1983;309:873-877.
31. Klee JG. Undiagnosed Wilson's disease as cause of unexplained miscarriage. Lancet 1979;2:423.
32. Kaushansky A, Frydman M, Kaufman H, Homburg R. Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration). Fertil Steril 1987;47:270-273.
33. Tarnacka B, Rodo M, Cichy S, Czlonkowska A. Procreation ability in Wilson's disease. Acta Neurol Scand 2000;101:395-398.
34. Walshe JM. Pregnancy in Wilson's disease. QJ Med 1977;46:73-83.
35. Wilson DC, Phillips MJ, Cox DW, Roberts EA. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr 2000;137:719-722.
36. Kalach N, Seidman EG, Morin C, Rasquin-Weber A, O'Regan S, Laberge JM, et al. Acute liver failure from Wilson's disease in a five year-old child. Can J Gastroenterol 1993;7:610-612.
37. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000;46:415-419.
38. Danks DM, Metz G, Sewell R, Prewett EJ. Wilson's disease in adults with cirrhosis but no neurological abnormalities. Br Med J 1990;301:331-332.
39. Fleming CR, Dickson ER, Wahner HW, Hollenhorst RW, McCall JT. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977;86:285-288.
40. Frommer D, Morris J, Sherlock S, Abrams J, Newman S. Kayser-Fleischer-like rings in patients without Wilson's disease. Gastroenterology 1977;72:1331-1335.
41. Tauber J, Steinert RF. Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease. A case report and literature review. Cornea 1993;12:74-77.
42. Dunn LL, Annable WL, Kliegman RM. Pigmented corneal rings in neonates with liver disease. J Pediatr 1987;110:771-776.
43. LaRusso NF, Summerskill WH, McCall JT. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976;70:653-655.
44. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991;115:720-726.
45. Emre S, Atillasoy EO, Ozdemir S, Schilsky M, Rathna Varma CV, Thung SN, et al. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 2001;72:1232-1236.
46. Sanchez-Albisua I, Garde T, Hierro L, Camarena C, Frauca E, de la Vega A, et al. A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood. J Pediatr Gastroenterol Nutr 1999;28:186-190.
47. Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. HEPATOLOGY 1992;15:609-615.
48. Giacchino R, Marazzi MG, Barabino A, Fasce L, Ciravegna B, Famularo L, et al. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases. Ital J Gastroenterol Hepatol 1997;29:155-161.
49. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996;46:1040-1043.
50. Cairns JE, Williams HP, Walshe JM. "Sunflower cataract" in Wilson's disease. Br Med J 1969;3:95-96.
51. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. HEPATOLOGY 1994;19:583-587.
52. Esmaeli B, Burnstine MA, Martonyi CL, Sugar A, Johnson V, Brewer GJ. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease. Cornea 1996;15:582-588.
53. Frieden E, Hsieh HS. Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol 1976;44:187-236.
54. Morell AG, Windsor J, Sternlieb I, Scheinberg IH. Measurement of the concentration of ceruloplasmin by determination of its oxidase activity. In: Sunderman SW, Sunderman SW, Jr., editors. Laboratory Diagnosis of Liver Diseases. St. Louis: Warren H. Green, 1968:193-195.
55. Schosinsky KH, Lehmann HP, Beeler MS. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974;20:1556-1563.
56. Rosenberg EB, Strickland GT, Feng YS, Blackwell RQ. Comparison of immunologic and enzymatic methods for ceruloplasmin quantitation in Wilson's disease. Taiwan I Hsueh Hui Tsa Chih 1971;70:49-53.
57. Endo F, Taketa K, Nakamura K, Awata H, Tanoue A, Eda Y, et al. Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease. J Inherit Metab Dis 1994;17:616-620.
58. Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson's disease. Lancet 1993;342:56-57.
59. Yamaguchi Y, Aoki T, Arashima S, Ooura T, Takada G, Kitagawa T, et al. Mass screening for Wilson's disease: results and recommendations. Pediatr Int 1999;41:405-408.
60. Fuhrman MP, Herrmann V, Masidonski P, Eby C. Pancyropenia after removal of copper from total parenteral nutrition. JPEN J Parenteral Enteral Nurr 2001;24:361-366.
61. Menkes JH. Menkes disease and Wilson disease: two sides of the same copper coin. Part I: Menkes disease. Europ J Paediatr Neurol 1999;3:147-158.
62. Edwards CQ, Williams DM, Cartwright GE. Hereditary hypoceruloplasminemia. Clin Genet 1979;15:311-316.
63. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67(suppl):972S-977S.
64. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997;27:358-362.
65. Perman JA, Werlin SL, Grand RJ, Watkins JB. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr 1979;94:564-568.
66. Lau JY, Lai CL, Wu PC, Pan HY, Lin HJ, Todd D. Wilson's disease: 35 years' experience. QJ Med 1990;75:597-605.
67. Walshe JM. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. QJ Med 1989;70:253-263.
68. Scheinberg IH, Sternlieb I. Wilson's disease. Philadelphia: Saunders, 1984.
69. Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1995:4125-4158.
70. Roberts EA, Cox DW. Wilson disease. Baillieres Clin Gastroenterol 1998;12:237-256.
71. Gaffney D, Fell GS, O'Reilly DS. ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol 2000;53:807-812.
72. Tu JB, Blackwell RQ. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967;16:507-513.
73. Gross JB, Jr., Ludwig J, Wiesner RH, McCall JT, LaRusso NF. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 1985;89:272-278.
74. Garcia-Villarreal L, Daniels S, Shaw SH, Cotton D, Galvin M, Geskes J, et al. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study. HEPATOLOGY 2000;32:1329-1336.
75. Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981;21:169-178.
76. Song YM, Chen MD. A single determination of liver copper concentration may misdiagnose Wilson's disease. Clin Biochem 2000;33:589-590.
77. 65Cu) in the differential diagnosis of Wilson's disease. Clin Sci (Colch) 1995;88:727-732.
78. Alt ER, Sternlieb I, Goldfischer S. The cytopathology of metal overload. Int Rev Exp Pathol 1990;31:165-188.
79. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol 1994;102:443-446.
80. Stromeyer FW, Ishak KG. Histology of the liver in Wilson's disease: a study of 34 cases. Am J Clin Pathol 1980;73:12-24.
81. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998;4:588-593.
82. Goldfischer S, Sternlieb I. Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol 1968;53:883-901.
83. Geller SA, Petrovic LM, Batts KB, Ferrell LM, Cohen C, Lewin K, et al. Histopathology of end-stage Wilson disease [Abstr]. Mod Pathol 2000;13:184A.
84. Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology 1968;55:354-367.
85. Feldmann G, Groussard O, Fauvert R. L'ultrastructure hθpatique au cours de la maladie de Wilson [Hepatic ultrastructure in Wilson's disease]. Biol Gastroenterol 1969;2:137-160.
86. Sternlieb I. Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease. HEPATOLOGY 1992;16:728-732.
87. Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver. An Atlas and Text of Ultrastructural Pathology. New York: Raven Press, 1987.
88. Sternlieb I, Feldmann G. Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study. Gastroenterology 1976;71:457-461.
89. Guan R, Oon CJ, Wong PK, Foong WC, Wee A. Primary hepatocellular carcinoma associated with Wilson's disease in a young woman. Postgrad Med J 1985;61:357-359.
90. Polio J, Enriquez RE, Chow A, Wood WM, Atterbury CE. Hepatocellular carcinoma in Wilson's disease. Case report and review of the literature. J Clin Gastroenterol 1989;11:220-224.
91. Cheng WS, Govindarajan S, Redeket AG. Hepatocellular carcinoma in a case of Wilson's disease. Liver 1992;12:42-45.
92. van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531-536.
93. Aisen AM, Martel W, Gabrielsen TO, Glazer GM, Brewer G, Young AB, et al. Wilson disease of the brain: MR imaging. Radiology 1985;157:137-141.
94. Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994;51:545-554.
95. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-278.
96. Thomas GR, Roberts EA, Walshe JM, Cox DW. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995;56:1315-1319.
97. Maier-Dobersberger T, Mannhalter C, Rack S, Granditsch G, Kaserer K, Korninger L, et al. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995;109:2015-2018.
98. Vidaud D, Assouline B, Lecoz P, Cadranel JF, Chappuis P. Misdiagnosis revealed by genetic linkage analysis in a family with Wilson disease. Neurology 1996;46:1485-1486.
99. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997;61:317-328.
100. Cossu P, Pirastu M, Nucaro A, Figus A, Balestrieri A, Borrone C, et al. Prenatal diagnosis of Wilson's disease by analysis of DNA polymorphism. N Engl J Med 1992;327:57.
101. Loudianos G, Figus AL, Loi A, Angius A, Dessi V, Deiana M, et al. Improvement of prenatal diagnosis of Wilson disease using microsatellite markers. Prenat Diagn 1994;14:999-1002.
102. Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, et al. Molecular characterization of Wilson disease in the Sardinian population - evidence of a founder effect. Hum Mutat 1999;14:294-303.
103. Thomas GR, Jensson O, Gudmundsson G, Thorsteinsson L, Cox DW. Wilson disease in Iceland: a clinical and genetic study. Am J Hum Genet 1995;56:1140-1146.
104. Kim EK, Yoo OJ, Song KY, Yoo HW, Choi SY, Cho SW, et al. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat 1998;11:275-278.
105. Nanji MS, Nguyen VT, Kawasoe JH, Inui K, Endo F, Nakajima T, et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet 1997;60:1423-1429.
106. Caca K, Ferenci P, Kuhn HJ, Polli C, Willgerodt H, Kunath B, et al. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001;35:575-581.
107. Firneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 2002;108:23-28.
108. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-217.
109. Palsson R, Jonasson JG, Kristjansson M, Bodvarsson A, Goldin RD, Cox DW, et al. Genotype-phenotype interactions in Wilson's disease: insight from an Icelandic mutation. Eur J Gastroenterol Hepatol 2001;13:433-436.
110. Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med 1977;86:301-303.
111. Hamlyn AN, Gollan JL, Douglas AP, Sherlock S. Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J 1977;2:660-662.
112. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983;84:161-167.
113. Rector WG, Jr., Uchida T, Kanel GC, Redeker AG, Reynolds TB. Fulminant hepatic and renal failure complicating Wilson's disease. Liver 1984;4:341-347.
114. Enomoto K, Ishibashi H, Irie K, Okumura Y, Nomura H, Fukushima M, et al. Fulminant hepatic failure without evidence of cirrhosis in a case of Wilson's disease. Jpn J Med 1989;28:80-84.
115. Ferlan-Marolt V, Stepec S. Fulminant Wilsonian hepatitis unmasked by disease progression: report of a case and review of the literature. Dig Dis Sci 1999;44:1054-1058.
116. Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. HEPATOLOGY 1986;6:859-863.
117. Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O'Grady J, Mowat A, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. HEPATOLOGY 1992;16:1206-1211.
118. Pitt P, Mowat A, Williams R, Hamilton E. Hepatic hypertrophic osteoarthropathy and liver transplantation. Ann Rheum Dis 1994;53:338-340.
119. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129-1134.
120. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986;27:1377-1381.
121. Zandman-Goddard G, Weiss P, Avidan B, Bar-Meir S, Shoenfeld Y. Acute varicella infection heralding Wilsonian crisis. J Clin Gastroenterol 1994;18:265-266.
122. Sallie R, Chiyende J, Tan KC, Bradley D, Portmann B, Williams R, et al. Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. Gut 1994;35:849-853.
123. Lembowicz K, Kryczka W, Walewska-Zielecka B, Kubicka J. Wilson's disease coexisting with viral hepatitis type C: a case report with histological and ultrastructural studies of the liver. Ultrastruct Pathol 1999;23:39-44.
124. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968;278:352-359.
125. Scheinberg IH, Sternlieb I, Schilsky M, Stockert RJ. Penicillamine may detoxify copper in Wilson's disease. Lancet 1987;ii:95.
126. Siegel RC. Collagen cross-linking effect of D-penicillamine on crosslinking in vitro. J Biol Chem 1977;252:254-259.
127. Lipsky PE, Ziff M. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol 1978;120:1006-1013.
128. Perrett D. The metabolism and pharmacology of D-penicillamine in man. J Rheumatol Suppl 1981;7:41-50.
129. Wiesner RH, Dickson ER, Carlson GL, McPhaul LW, Go VLW. The pharmacokinetics of D-penicillamine in man. J Rheumatol Suppl 1981;7:51-55.
130. Bergstrom RF, Kay DR, Harkcom TM, Wagner JG. Penicillamine kinetics in normal subjects. Clin Pharmacol Ther 1981;30:404-413.
131. Schuna A, Osman MA, Patel RB, Welling PB, Sundstrom WR. Influence of food on the bioavailability of penicillamine. J Rheumatol 1983;10:95-97.
132. Kukovetz WR, Beubler E, Kreuzig F, Moritz AJ, Nimberger G, WernerBreitnecker L. Bioavailability and pharmacokinetics of D-penicillamine. J Rheumatol 1983;10:90-94.
133. Wei P, Sass-Kortsak A. Urinary excretion and renal clearance of D-penicillamine in humans and the dog. Gastroenterology 1970;58:288.
134. Falkmer S, Samuelson G, Sjolin S. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Pediatrics 1970;45:260-268.
135. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973;42:441-452.
136. Sass-Kortsak A. Wilson's disease. A treatable liver disease in children. Pediatr Clin North Am 1975;22:963-984.
137. Grand RJ, Vawter GF. Juvenile Wilson disease: histologic and functional studies during penicillamine therapy. J Pediatr 1975;87:1161-1170.
138. Sternlieb I. Copper and the liver. Gastroenterology 1980;78:1615-1628.
139. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996;243:269-273.
140. Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. QJ Med 1993;86:197-204.
141. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-493.
142. Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987;317:209-213.
143. Deutscher J, Kiess W, Scheerschmidt G, Willgerodt H. Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease. J Pediatr Gastroenterol Nutr 1999;29:628.
144. Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, et al. Iron accumulation in the liver of male patients with Wilson disease. Am J Gastroenterol 2001;96:3147-3151.
145. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-647.
146. Walshe JM. The management of pregnancy in Wilson's disease treated with trientine. QJ Med 1986;58:81-87.
147. Kodama H, Murata Y, Iitsuka T, Abe T. Metabolism of administered triethylene retramine dihydrochloride in humans. Life Sci 1997;61:899-907.
148. Sarkar B, Sass-Kortsak A, Clarke R, Laurie SH, Wei P. A comparative study of in vitro and in vivo interaction of D-penicillamine and triethylene-tetramine with copper. Proc R Soc Med 1977;70(Suppl 3):13-18.
149. Borthwick TR, Benson GD, Schugar HJ. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine. J Lab Clin Med 1980;95:575-580.
150. Walshe JM. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1). Prog Clin Biol Res 1979;34:271-280.
151. Santos Silva EE, Sarles J, Buts JP, Sokal EM. Successful medical treatment of severely decompensated Wilson disease. J Pediatr 1996;128:285-287.
152. Saito H, Watanabe K, Sahara M, Mochizuki R, Edo K, Ohyama Y. Triethylene-tetramine (trien) therapy for Wilson's disease. Tohoku J Exp Med 1991;164:29-35.
153. Epstein O, Sherlock S. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis. Gastroenterology 1980;78:1442-1445.
154. Shiono Y, Hayashi H, Wakusawa S, Yano M. Ultrastructural identification of iron and copper accumulation in the liver of a male patient with Wilson disease. Med Electron Microsc 2001;34:54-60.
155. Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987;77:137-146.
156. Hoogenraad TU, Koevoet R, de Ruyter Korver EG. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18:205-211.
157. Brewer GJ, Yuzbasiyan-Gurkan V, Young AB. Treatment of Wilson's disease. Semin Neurol 1987;7:209-220.
158. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-319.
159. Schilsky M, Blank RR, Czaja MJ, Scheinberg IH, Stockert RJ, Sternlieb I. Hepatocellular copper toxicity and its attenuation by zinc. J Clin Invest 1989;84:1562-1568.
160. Hill GM, Brewer GJ, Prasad AS, Hydrick CR, Hartmann DE. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens. HEPATOLOGY 1987;7:522-528.
161. Cousins RJ. Absorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65:238-309.
162. Walshe JM, Munro NA. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Arch Neurol 1995;52:10-11.
163. Lang CJ, Rabas-Kolominsky P, Engelhardt A, Kobras G, Konig HJ. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol 1993;50:1007-1008.
164. Brewer GJ, Johnson V, Kaplan J. Treatment of Wilson's disease with zinc: XIV. S tudies of the effect of zinc on lymphocyte function. J Lab Clin Med 1997;129:649-652.
165. Alexiou D, Hatzis T, Koutselinis A. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years]. Arch Fr Pediatr 1985;42:447-449.
166. Van Caillie-Bertrand M, Degenhart HJ, Visser HK, Sinaasappel M, Bouquet J. Oral zinc sulphate for Wilson's disease. Arch Dis Child 1985;60:656-659.
167. Milanino R, Deganello A, Marrella M, Michielutti F, Moretti U, Pasqualicchio M, et al. Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child. Acta Paediatr 1992;81:163-166.
168. Brewer GJ, Dick RD, Johnson VD, Fink JK, Kluin KJ, Daniels S. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001;137:191-198.
169. Pecoud A, Dozel F, Schelling JL. The effect of foodstuffs on the absorption of zinc sulfate. Clin Pharmacol Ther 1975;17:469.
170. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 1994;20:41-46.
171. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 1995;37:219-226.
172. Sokol RJ, Twedt D, McKim JM, Jr., Devereaux MW, Karrer FM, Kam I, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994;107:1788-1798.
173. Brewer GJ, Yuzbasiyan-Gurkan V, Dick R, Wang Y, Johnson V. Does a vegetarian diet control Wilson's disease? J Am Coll Nutr 1993;12:527-530.
174. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996;53:1017-1025.
175. Walshe JM. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet 1988;2:435-437.
176. Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY, Appelman H. Treatment of Wilson's disease with zinc. VI. Initial treatment studies. J Lab Clin Med 1989;114:633-638.
177. Walshe JM, Dixon AK. Dangers of non-compliance in Wilson's disease. Lancet 1986;1:845-847.
178. Sokol RJ, Francis PD, Gold SH, Ford DM, Lum GM, Ambruso DR. Orthotopic liver transplantation for acute fulminant Wilson disease. J Pediatr 1985;107:549-552.
179. Kiss JE, Berman D, Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson's disease. Transfusion 1998;38:327-331.
180. Rakela J, Kurtz SB, McCarthy JT, Krom RA, Baldus WP, McGill DB, et al. Postdilution hemofiltration in the management of acute hepatic failure: a pilot study. Mayo Clin Proc 1988;63:113-118.
181. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, et al. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology 1986;90:2004-2007.
182. Sarles J, Lefevre P, Picon G. Plasma exchange for fulminant Wilson disease. Eur J Pediatr 1992;151:310.
183. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-1085.
184. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-330.
185. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, et al. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002;8:962-967.
186. Shimono N, Ishibashi H, Ikematsu H, Kudo J, Shirahama M, Inaba S, et al. Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson's disease. Gastroenterol Jpn 1991;26:69-73.
187. Morimoto I, Ninomiya H, Komatsu K, Satho M. Pregnancy and penicillamine treatment in a patient with Wilson's disease. Jpn J Med 1986;25:59-62.
188. Dupont P, Irion O, Beguin F. Pregnancy in a patient with treated Wilson's disease: a case report. Am J Obstet Gynecol 1990;163:1527-1528.
189. Soong YK, Huang HY, Huang CC, Chu NS. Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease. J Formos Med Assoc 1991;90:693-696.
190. Devesa R, Alvarez A, de las Heras G, Ramon de Miguel J. Wilson's disease treated with trientine during pregnancy. J Pediatr Gastroenterol Nutr 1995;20:102-103.
191. Lao TT, Chin RK, Cockram CS, Leung NW. Pregnancy in a woman with Wilson's disease treated with zinc. Asia Oceania J Obstet Gynaecol 1988;14:167-169.
192. Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. HEPATOLOGY 2000;31:364-370.
193. Endres W. D-penicillamine in pregnancy - to ban or not to ban? Klin Wochenschr 1981;59:535-537.
194. Biller J, Swiontoniowski M, Brazis PW. Successful pregnancy in Wilson's disease: a case report and review of the literature. Eur Neurol 1985;24:306-309.
195. Hartard C, Kunze K. Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature. Eur Neurol 1994;34:337-340.
196. Nunns D, Hawthorne B, Goulding P, Maresh M. Wilson's disease in pregnancy. Eur J Obstet Gynecol Reprod Biol 1995;62:141-143.
197. Sternlieb I. Wilson's disease and pregnancy. HEPATOLOGY 2000;31:531-532.
198. Groth CG, Dubois RS, Corman J, Gustafsson A, Iwatsuki S, Rodgerson DO, et al. Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc 1973;5:829-833.
199. Eghtesad B, Nezakatgoo N, Geraci LC, Jabbour N, Irish WD, Marsh W, et al. Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg 1999;5:467-474.
200. Asonuma K, Inomata Y, Kasahara M, Uemoto S, Egawa H, Fujita S, et al. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999;3:201-205.
201. Schumacher G, Platz KP, Mueller AR, Neuhaus R, Steinmuller T, Bechstein WO, et al. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease. Clin Transplant 1997;11:217-224.
202. Bax RT, Hassler A, Luck W, Hefter H, Krageloh-Mann I, Neuhaus P, et al. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 1998;51:863-865.
203. Lui CC, Chen CL, Cheng YF, Lee TY. Recovery of neurological deficits in a case of Wilson's disease after liver transplantation. Transplant Proc 1998;30:3324-3325.
204. Stracciari A, Tempestini A, Borghi A, Guarino M. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol 2000;57:384-386.
205. Wu JC, Huang CC, Jeng LB, Chu NS. Correlation of neurological manifestations and MR images in a patient with Wilson's disease after liver transplantation. Acta Neurol Scand 2000;102:135-139.
206. Guarino M, Stracciari A, D'Alessandro R, Pazzaglia P. No neurological improvement after liver transplantation for Wilson's disease. Acta Neurol Scand 1995;92:405-408.
207. Kassam N, Witt N, Kneteman N, Bain VG. Liver transplantation for neuropsychiatric Wilson disease. Can J Gastroenterol 1998;12:65-68.
208. Brewer GJ, Askari F. Transplant livers in Wilson's disease for hepatic, not neurologic, indications. Liver Transpl 2000;6:662-664.